| Value | ₹1,107 Cr |
|---|
BSE filing, NSE: NILKAMAL. Summary written from the filing by ALFA Finder's alert engine.
Nilkamal Ltd: key numbers
- Share price
- ₹2,003.90
- Market cap
- ₹2,990 Cr
- Revenue (annual)
- ₹3,778 Cr
- Net profit (annual)
- ₹115.6 Cr
- P/E (TTM)
- 18.8×Sector 52.8×
- Promoter holding
- 64.54%+0.00% QoQ
- FII holding
- 1.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nilkamal Ltd
All →Nilkamal Debt & Borrowing
Nilkamal filed its statutory auditor's security cover certificate for secured NCDs as of September 30, 2026. The auditor confirmed the company maintained the required 125% cover.
Nilkamal Q2 FY27 Results: Net Profit ₹67.8 Cr, Up 101.2% YoY
Nilkamal Ltd reported revenue from operations of ₹1,126 Cr (+16.3% YoY) and net profit of ₹67.8 Cr (+101.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹67.8 Cr · +101.2% YoY
Nilkamal Management Change
Nilkamal's Chief Human Resources Officer, Maya Verma, has resigned, effective 30 November 2026. She is a designated Senior Management Personnel of the company.
Nilkamal Board Meeting Date
Nilkamal Limited intimated a board meeting scheduled for October 29, 2026 to approve unaudited results. The trading window is closed pending the results announcement.
Nilkamal Other Announcement
Nilkamal Ltd has filed its quarterly shareholding pattern statement for the quarter ended September 30, 2026.
Nilkamal Debt & Borrowing: ₹24.01 Cr
Nilkamal Limited submitted its half-yearly ISIN statement for debt securities as of September 30, 2026. The company reports an outstanding debt amount of ₹24.01 Crore.
- Value
- ₹24.01 Cr
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.